Fluvoxamine

CHEMBL814 Phase 4 Zugelassen Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

318.3 g/mol

LogP

2.6

Phase

4

This selective serotonin reuptake inhibitor increases serotonin availability in the brain and is primarily used to treat obsessive-compulsive disorder as well as depression and anxiety disorders. It has also been studied for its potential anti-inflammatory effects in other conditions.

Molekularmasse

318,3300 g/mol

LogP

2,60

TPSA

56,80 Å²

Lipinski-Regel der Fünf

Bestanden

Therapeutische Bereiche

Cardiovascular Disease Respiratory Disease Pain Management Chronic Obstructive Pulmonary Disease Alzheimer's Disease Parkinson's Disease Schizophrenia Bipolar Disorder Generalized Anxiety Disorder Infectious Disease Gastroesophageal Reflux Disease Inflammatory Bowel Disease Chronic Kidney Disease Non-Alcoholic Fatty Liver Disease Major Depressive Disorder Breast Cancer Chronic Pain

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D-Struktur

SVG PNG

Cite this structure

Embed this structure

SMILES

COCCCC/C(=N\OCCN)c1ccc(C(F)(F)F)cc1

InChI

InChI=1S/C15H21F3N2O2/c1-21-10-3-2-4-14(20-22-11-9-19)12-5-7-13(8-6-12)15(16,17)18/h5-8H,2-4,9-11,19H2,1H3/b20-14+

Molecular Formula

C15H21F3N2O2

HBD / HBA

1 / 7

Rotierbare Bindungen

9

Schwere Atome

22

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Häufig gestellte Fragen

This selective serotonin reuptake inhibitor increases serotonin availability in the brain and is primarily used to treat obsessive-compulsive disorder as well as depression and anxiety disorders. It has also been studied for its potential anti-inflammatory effects in other conditions.

Yes, Fluvoxamine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL814. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 5324346. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Suchen Sie patientenfreundliche Informationen?

Fluvoxamine auf PillFYI

Struktur

Schnelldaten

Formel: C15H21F3N2O2
Synonyme: 1

Externe Links

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Medizinischer Haftungsausschluss

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.